BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30568391)

  • 1. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
    Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
    World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
    Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
    Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis.
    Tang J; Liu J; Du B; Zhang J; Zheng L; Wang X; Wan Y
    Tech Coloproctol; 2023 Jan; 27(1):43-52. PubMed ID: 36194310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life after extensive pelvic surgery].
    Levý M; Lipská L; Visokai V; Šimša J
    Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.
    Yang H; Yao Z; Cui M; Xing J; Zhang C; Zhang N; Liu M; Xu K; Tan F; Su X
    BMC Cancer; 2020 Aug; 20(1):761. PubMed ID: 32795280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
    Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
    Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
    Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
    Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
    Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
    Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
    Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.